Carteolol (Carteolol Hydrochloride)
125
relevant articles (14 outcomes,
23 trials/studies)
found for this Drug
Description:
A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Also Known As:
Carteolol Hydrochloride; Carteolol Monohydrochloride; OPC-1085; Hydrochloride, Carteolol; Monohydrochloride, Carteolol; OPC 1085; OPC1085; 2(1H)-Quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-
Relationship Network
Drug Context: Research Results